FDA Approval Activities for this Drug…

Detrol LA Extended Release Capsules, Pharmacia and Upjohn NDA 21-228/S4 7/21/03 7/28/03 Detrol LA Capsules, 2 and 4 mg extended release, Pharmacia and Upjohn NDA 21-228/S1 4/27/01 5/1/03 Detrol LA Capsules, 2 and 4 mg extended release, Pharmacia and Upjohn NDA 21-228 12/22/00 1/9/01 1/9/01 Detrol Indications: overactive bladder with symptoms of urge urinary incontinence, urgency and frequency Detrol (Tolterodine Tartrate) Tablets, Pharmacia and Upjohn NDA 20-771/S-010 7/21/03 7/28/03 Detrol (Tolterodine Tartrate) Tablets, 1 and 2 mg, Pharmacia and Upjohn NDA 20-771/S-004 4/6/01 4/9/01 4/9/01 Detrol (Tolterodine Tartrate), 1 and 2 mg Pharmacia and Upjohn NDA 20-771 Detrol LA Extended Release Capsules, Pharmacia and Upjohn

For the latest approval information, please locate this drug using this index.